PB1879: EFFICACY AND SAFETY OF CPX-351 COMPARED TO STANDARD OF CARE CHEMOTHERAPY IN A REAL-LIFE SETTING: SUPPORTING PREVIOUS EVIDENCE AND FACING NEW CHALLENGES

por Manghisi, Beatrice, Alberti, Sara, Ripamonti, Alessia, Perfetti, Paola, Borin, Lorenza Maria, Fumagalli, Monica, Passerini, Carlo Gambacorti
Publicado 2023

Safety and Effectiveness of Intensive Treatments Administered Outside the Intensive Care Unit to Hematological Critically Ill Patients: An Intensive Care without Walls Trial

por Vergnano, Beatrice, Signori, Davide, Benini, Annalisa, Calcinati, Serena, Bettini, Francesca, Verga, Luisa, Borin, Lorenza Maria, Cavalca, Fabrizio, Gambacorti-Passerini, Carlo, Bellani, Giacomo, Foti, Giuseppe
Publicado 2023

Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID‐19 vaccine: A single‐center prospective observational study (NC...

por Bossi, Elisa, Aroldi, Andrea, Borin, Lorenza Maria, Verga, Luisa, Fontana, Diletta, Cocito, Federica, Manghisi, Beatrice, Rindone, Giovanni, Cavalca, Fabrizio, Ripamonti, Alessia, Raggi, Monica, Malandrin, Sergio Maria Ivano, Cavallero, Annalisa, Antolini, Laura, Bonardi, Diego, Piazza, Rocco Giovanni, Gambacorti‐Passerini, Carlo
Publicado 2022